Newborn bloodspot screening is used to identify babies who have rare but serious conditions.
We have now completed a pilot project that evaluated whether newborn screening should be expanded to include a further five rare conditions.
The outcome of the project is that screening for four of the conditions will be offered in England from early 2015. Screening for all five conditions is still available at the project’s pilot sites until Friday 29 August 2014. From Monday 1 September 2014 LCHADD screening will be discontinued so samples received in the pilot laboratories will be screened for four conditions.
This website provides information developed during the pilot project for parents and professionals on the newborn screening process, the rare conditions which are being tested, and the research study.
Please note that this website is no longer being actively managed but is being maintained for information.